Clinical Trials Browser

Phase 3 × Colorectal Cancer Metastatic × Vemurafenib × Clear all

NCT06008119 2025-09-18

Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

Phase 3 Recruiting

Gastrointestinal

Colorectal Cancer Metastatic